Inhibitor Therapeutics INTI
OTC INTI
$0.08 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Inhibitor Therapeutics (INTI) Long-Term Debt Issuances (2020 - 2022)

Updated

Inhibitor Therapeutics' Long-Term Debt Issuances was $180,000 in FY2022, up 2.3% from $176,000 in FY2021.

Analysis

Inhibitor Therapeutics (INTI) Long-Term Debt Issuances (2020 - 2022) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $176,000 in FY2021 (+220.0%) and $55,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Inhibitor Therapeutics 13.90 Mn 6.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 80,000.00
Jun 30, 2022 50,000.00
Mar 31, 2022 50,000.00
Jun 30, 2021 75,000.00
Mar 31, 2021 101,000.00
Dec 31, 2020 55,000.00
Jun 30, 2020 41,600.00
API Access

Inhibitor Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=INTI&period=max&api_key=YOUR_API_KEY